Search results :

Nicardipine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C08CA04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Headache 2.5% - 15% 1.4% - 7.1% x x x x x x x x x
Hypotension 5% - 6% 1% x x x x x x x x x
Nausea 1.2% - 4.9% 0% - 1% x x x x x x x x x
Vomiting 0.6% - 5% 0% - 1% x x x x x x x x x
Tachycardia 0.9% - 4% 0% x x x x x x x x x
Foot edema 0.576% - 5.9% 0% - 1.4% x x x x
Palpitations 2.2% - 2.8% 0% - 1.4% x x x x
Dizziness 0.288% - 3.3% 0% - 0.7% x x x x x
Orthostatic hypotension 0.9% - 1.4% 0% x x x x x
Polyuria 1.4% 0% x
Sweating 1.4% 0% x
Ventricular extrasystoles 1.4% 0% x x x x x
Injection site reaction 1.4% 0% x
Asthenia 0.7% - 4.4% 0% - 0.7% x x x x x
Diarrhoea 0.9% 0% x x
Rash 0.6% - 0.9% 0% - 0.7% x x x x
Abdominal pain 0.7% 0% x
Chest pain 0.6% - 0.7% 0% x x x x x
Dyspnoea 0.7% 0% x x x
Haematuria 0.7% 0% x
Pericardial haemorrhage 0.7% 0% x
Hypertension 0.7% 0% x
Hypoaesthesia 0.7% 0% x
Hypokalaemia 0.7% 0% x
Paraesthesia 0.192% - 0.7% 0% x x x
Syncope 0.7% 0% x x x
Supraventricular tachycardia 0.7% 0% x
Vasodilation 0.7% 0% x x x x x
Ventricular tachycardia 0.7% 0% x x x x x
Haemorrhage intracranial 0.7% 0% x
Injection site pain 0.7% 0% x
Extrasystoles 0.7% 0% x
Myocardial infarction 0.6% 0% x x x x x x x x x
Pain 0.6% 0% x x
Pollakiuria 0.6% 0% x x x x x x x x x
Vision blurred 0.6% 0% x x x x
Face oedema 0.6% 0% x x
Sweating increased 0.6% 0% x x
Oedema 0.192% 0% x x
Myalgia 0.192% 0% x x
Oxygen saturation decreased postmarketing x
Angina pectoris x x x x x x x
Anxiety x x x x
Arthralgia x x x x
Atrial fibrillation x x
Atrioventricular block x x x x x
Neck pain x x x x x
Infection x x x x
Confusional state x x x x x x x x x
Conjunctivitis x x x x x
Constipation x x
Dyspepsia x x x x x x x
Ear disorder x x x x x
Body temperature increased x x x x x
Flushing 0.323% x x
Block heart x x
Hypersensitivity x x x x
Hypertonia x x x x x
Nervousness x x
Nocturia 0% x x
Pericarditis x x
Rhinitis x x x x
Sinusitis x x x x
Thrombocytopenia x x x x x
Tinnitus x x x x x x x x x
Tremor 0% x x
Vertigo x x x x
Dry mouth 0% x x
Peripheral vascular disorder x x x x
Oedema peripheral x x x x x
Hypophosphataemia x x x x x
Deep vein thrombosis x x x x x
Malaise 0% x x
Abnormal dreams 0% x x
Angina pectoris aggravated x x
Erectile dysfunction x x x x
Throat sore x x x x
Disease progression x x x x x
Hyperkinesia x x x x
Sinoatrial node dysfunction x x x x x
Electrocardiogram ST segment depression x x x x x
Electrocardiogram T wave inversion x x x x x
Electrocardiogram abnormal 0% x x
Hot flush x x x x
Cerebral ischaemia x x
Insomnia 0% x x
Somnolence 0% - 0.323% x x
Abnormal vision x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

NICARDIPINE

Side effects:26
Source:FDA Structured Product Label

NICARDIPINE

Side effects:26
Source:FDA Structured Product Label

NICARDIPINE

Side effects:26
Source:FDA Structured Product Label

NICARDIPINE

Side effects:27
Source:FDA Structured Product Label

NICARDIPINE

Side effects:48
Source:FDA Structured Product Label

NICARDIPINE

Side effects:37
Source:FDA Structured Product Label

NICARDIPINE

Side effects:37
Source:FDA Structured Product Label

NICARDIPINE

Side effects:54
Source:FDA Structured Product Label

Nicardipine

Side effects:54
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label